taurolidine has been researched along with Skin Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baumann, K; Dummer, R; French, LE; Goldinger, SM; Imhof, L; Röthlisberger, P; Schad, K | 1 |
Gong, SL; Liu, LL; Redmond, HP; Sun, BS; Wang, JH | 1 |
1 trial(s) available for taurolidine and Skin Neoplasms
Article | Year |
---|---|
The antibacterial substance, taurolidine in the second/third-line treatment of very advanced stage IV melanoma including brain metastases: results of a phase 2, open-label study.
Topics: Adult; Aged; Anti-Infective Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Disease Progression; Female; Humans; Infusions, Intravenous; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prospective Studies; Skin Neoplasms; Taurine; Thiadiazines; Treatment Outcome | 2011 |
1 other study(ies) available for taurolidine and Skin Neoplasms
Article | Year |
---|---|
Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; In Situ Nick-End Labeling; Injections, Intraperitoneal; Maximum Tolerated Dose; Melanoma; Mice; Mice, Inbred C57BL; Skin Neoplasms; Taurine; Thiadiazines; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2007 |